MOLECULAR PARTNERS N/ CH0256379097 /
| 2024-04-19 5:30:11 PM | Chg. +0.0200 | Volume | Bid5:40:00 PM | Ask5:40:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 3.3700CHF | +0.60% | 24,802 Turnover: 82,200.5750 |
3.2750Bid Size: 53 | 3.5000Ask Size: 3,000 | 122.51 mill.CHF | - | - |
Assets
| 2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
2021 IFRS in mill. CHF |
2022 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 1.5000 | 4.2000 | 9.4000 | 8.1000 | 7.2350 | ||||||
| Intangible Assets | .4000 | .8000 | .3000 | .3000 | .2710 | ||||||
| Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | - | ||||||
| Fixed Assets | 1.8000 | 5 | 9.7000 | 8.5000 | 7.5060 | ||||||
| Inventories | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Accounts Receivable | 51.6000 | 2.3000 | 2.8000 | 25.7000 | .5000 | ||||||
| Cash and Cash Equivalents | 99 | 75.7000 | 133.7000 | 71.8000 | 87.9460 | ||||||
| Current Assets | 153.3000 | 99.9000 | 177.8000 | 164.2000 | 254.7520 | ||||||
| Total Assets | 155.2000 | 104.9000 | 187.5000 | 172.7000 | 262.2580 | ||||||
Liabilities
| 2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
2021 IFRS in mill. CHF |
2022 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 2.6000 | 2.4000 | 5.8000 | 7.4000 | .9970 | ||||||
| Long-term debt | - | - | - | - | - | ||||||
| Liabilities to Banks | 0.0000 | 0.0000 | 0.0000 | 0.0000 | - | ||||||
| Provisions | 6.4000 | 6.6000 | 7.7000 | 10 | - | ||||||
| Liabilities | 63.5000 | 50.8000 | 80.3000 | 65.4000 | 27.0920 | ||||||
| Share Capital | 2.1000 | 2.1600 | 2.9150 | 3.2290 | - | ||||||
| Total Equity | 91.7000 | 54.1000 | 107.2000 | 107.3000 | 235.1660 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 155.2000 | 104.9000 | 187.5000 | 172.7000 | 262.2580 | ||||||
Income Statement
| 2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
2021 IFRS in mill. CHF |
2022 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 10.4000 | 20.4000 | 9.3000 | 9.8000 | 189.6000 | ||||||
| Depreciation (total) | .9000 | - | - | - | - | ||||||
| Operating Result | -37.4000 | -36.7000 | -58.3000 | -63.4000 | 116.6130 | ||||||
| Interest Income | - | - | - | - | 1.2400 | ||||||
| Income Before Taxes | -37 | -36.3000 | -62.8000 | -63.8000 | - | ||||||
| Income Taxes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -37 | -36.3000 | -62.8000 | -63.8000 | 117.8530 | ||||||
Per Share
Cash Flow
| 2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
2021 IFRS in mill. CHF |
2022 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -42.5000 | -1.2000 | -29 | -91 | 118.5660 | ||||||
| Cash Flow from Investing Activities | 9.6000 | -19.8000 | -21.7000 | -22.2000 | -101.1210 | ||||||
| Cash Flow from Financing | .4000 | -.2000 | 113.2000 | 50.6000 | -1.5700 | ||||||
| Decrease / Increase in Cash | -32.4000 | -23.2000 | 58 | -61.9000 | - | ||||||
| Employees | 118 | 145 | 157 | 163 | 191 | ||||||
